mRNA levels of ESR1 and HER2 as predictive and prognostic markers of breast cancer

被引：0
作者：
Park, In Hae [1 ]
Ro, Jungsil [1 ]
机构：
[1] Natl Canc Ctr, Ctr Breast Canc, Kashiwa, Chiba, Japan
来源：
PHARMACOGENOMICS | 2013年 / 14卷 / 11期
关键词：
BEVACIZUMAB; EXPRESSION; THERAPY;
D O I：
10.2217/pgs.13.101
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1251 / 1253
页数：3
相关论文
共 50 条
[31]   Correlation of HER2 Protein Level With mRNA Level Quantified by RNAscope in Breast Cancer [J].
Li, Xiaoxian ;
Lee, Ji-Hoon ;
Gao, Yuan ;
Zhang, Jilun ;
Bates, Katherine M. ;
Rimm, David L. ;
Zhang, Huina ;
Smith, Geoffrey Hughes ;
Lawson, Diane ;
Meisel, Jane ;
Chang, Jenny ;
Huo, Lei .
MODERN PATHOLOGY, 2024, 37 (02)
[32]   Antisense oligodeoxynucleotide targeting HER2 mRNA sensitized docetaxel in breast cancer treatment [J].
Sun, Junzhong ;
Xu, Yin ;
Song, Santai ;
Wu, Zuze ;
Duan, Haifeng .
PHARMACEUTICAL BIOLOGY, 2011, 49 (11) :1167-1172
[33]   Tracking and Evaluating Molecular Tumor Markers With Cancer Registry Data: HER2 and Breast Cancer [J].
Anderson, William F. ;
Rosenberg, Philip S. ;
Katki, Hormuzd A. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (05)
[34]   Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer [J].
Aurilio, Gaetano ;
Sandri, Maria Teresa ;
Pruneri, Giancarlo ;
Zorzino, Laura ;
Botteri, Edoardo ;
Munzone, Elisabetta ;
Adamoli, Laura ;
Facchi, Giuseppina ;
Cullura, Daniela ;
Verri, Elena ;
Rocca, Maria Cossu ;
Zurrida, Stefano ;
Iacovelli, Roberto ;
Nole, Franco .
FUTURE ONCOLOGY, 2016, 12 (17) :2001-2008
[35]   Evolving Role of the Estrogen Receptor as a Predictive Biomarker: ESR1 Mutational Status and Endocrine Resistance in Breast Cancer [J].
Lauring, Josh ;
Wolff, Antonio C. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) :2950-+
[36]   Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH [J].
Jensen, Steffen Grann ;
Thomas, Peter Engel ;
Christensen, Ib Jarle ;
Balslev, Eva ;
Hansen, Alastair ;
Hogdall, Estrid .
APMIS, 2020, 128 (11) :573-582
[37]   Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer [J].
Eggemann, Holm ;
Ignatov, Tanja ;
Burger, Elke ;
Kantelhardt, Eva Johanna ;
Fettke, Franziska ;
Thomssen, Christoph ;
Costa, Serban Dan ;
Ignatov, Atanas .
ENDOCRINE-RELATED CANCER, 2015, 22 (05) :725-733
[38]   Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer [J].
Jerjees, Dena A. ;
Alabdullah, M. ;
Green, Andrew R. ;
Alshareeda, Alaa ;
Macmillan, R. D. ;
Ellis, Ian O. ;
Rakha, Emad A. .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (02) :317-330
[39]   Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer [J].
Castagnoli, Lorenzo ;
Iorio, Egidio ;
Dugo, Matteo ;
Koschorke, Ada ;
Faraci, Simona ;
Canese, Rossella ;
Casalini, Patrizia ;
Nanni, Patrizia ;
Vernieri, Claudio ;
Di Nicola, Massimo ;
Morelli, Daniele ;
Tagliabue, Elda ;
Pupa, Serenella M. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) :1768-1779
[40]   Impact of Serum HER2 Levels on Survival and Its Correlation with Clinicopathological Parameters in Women with Breast Cancer [J].
Ryu, Dong Won ;
Lee, Chung Han .
JOURNAL OF BREAST CANCER, 2012, 15 (01) :71-78
12345